XOM
161.17
+0.95%↑
CVX
204.7
+1.5%↑
SHEL.US
90.76
+0.32%↑
TTE.FR
76
+1.05%↑
COPNY
127.33
+0.39%↑
XOM
161.17
+0.95%↑
CVX
204.7
+1.5%↑
SHEL.US
90.76
+0.32%↑
TTE.FR
76
+1.05%↑
COPNY
127.33
+0.39%↑
XOM
161.17
+0.95%↑
CVX
204.7
+1.5%↑
SHEL.US
90.76
+0.32%↑
TTE.FR
76
+1.05%↑
COPNY
127.33
+0.39%↑
XOM
161.17
+0.95%↑
CVX
204.7
+1.5%↑
SHEL.US
90.76
+0.32%↑
TTE.FR
76
+1.05%↑
COPNY
127.33
+0.39%↑
XOM
161.17
+0.95%↑
CVX
204.7
+1.5%↑
SHEL.US
90.76
+0.32%↑
TTE.FR
76
+1.05%↑
COPNY
127.33
+0.39%↑
24h
Actuel
Min
104.66
Max
108.75
Revenu | 6M 553M |
|---|---|
Ventes | 373M 3.3B |
P/E Moyenne du Secteur | 14.254 66.822 |
Rendement du dividende | 3.38 |
Marge bénéficiaire | 16.557 |
Employés | 1,600 |
Recommandations | Achat Fort |
|---|---|
Prévisions sur 12 Mois | +24.77% upside |
Rendement du dividende Moyenne du Secteur | 3.38% 3.56% |
|---|---|
Prochains Résultats | 28 avr. 2026 |
Date du Prochain Dividende | 26 mars 2026 |
Date du Prochain Détachement de Dividende | 14 mai 2026 |
Capitalisation Boursière | 23B |
|---|---|
Ouverture précédente | 107.3 |
Clôture précédente | 107.66 |
Les performances passées ne sont pas un indicateur fiable des résultats futurs.
23 mars 2026, 23:47 UTC
Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update
DJ
Lire
23 mars 2026, 22:55 UTC
Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion
DJ
Lire
23 mars 2026, 21:51 UTC
Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update
DJ
Lire
23 mars 2026, 23:59 UTC
Global Equities Roundup: Market Talk
DJ
Lire
23 mars 2026, 23:59 UTC
Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk
DJ
Lire
23 mars 2026, 23:50 UTC
Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk
DJ
Lire
23 mars 2026, 23:37 UTC
Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk
DJ
Lire
23 mars 2026, 22:42 UTC
Global Equities Roundup: Market Talk
DJ
Lire
23 mars 2026, 22:42 UTC
Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk
DJ
Lire
23 mars 2026, 22:40 UTC
Gilead Sciences to Buy Ouro Medicines for Up to $2.18B
DJ
Lire
23 mars 2026, 22:23 UTC
Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk
DJ
Lire
23 mars 2026, 22:22 UTC
Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease
DJ
Lire
23 mars 2026, 22:21 UTC
Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales
DJ
Lire
23 mars 2026, 22:21 UTC
Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China
DJ
Lire
23 mars 2026, 22:20 UTC
Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD
DJ
Lire
23 mars 2026, 22:20 UTC
Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD
DJ
Lire
23 mars 2026, 22:19 UTC
Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders
DJ
Lire
23 mars 2026, 22:19 UTC
Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets
DJ
Lire
23 mars 2026, 22:18 UTC
Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD
DJ
Lire
23 mars 2026, 22:15 UTC
Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD
DJ
Lire
23 mars 2026, 22:08 UTC
Ebos Needs to Reset Its Gearing Targets -- Market Talk
DJ
Lire
23 mars 2026, 21:42 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Lire
23 mars 2026, 21:42 UTC
RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk
DJ
Lire
23 mars 2026, 21:32 UTC
WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK
DJ
Lire
23 mars 2026, 21:32 UTC
WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK
DJ
Lire
23 mars 2026, 21:32 UTC
WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK
DJ
Lire
23 mars 2026, 21:10 UTC
Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com
DJ
Lire
23 mars 2026, 20:50 UTC
Tech, Media & Telecom Roundup: Market Talk
DJ
Lire
23 mars 2026, 20:50 UTC
Health Care Roundup: Market Talk
DJ
Lire
23 mars 2026, 20:50 UTC
Basic Materials Roundup: Market Talk
DJ
Lire
Variation de prix
By TipRanks
Prévisions sur 12 Mois
Moyen 133.9 USD 24.77%
Haut 160 USD
Bas 109 USD
Basé sur 22 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.
By TipRanks
Achat Fort
22 ratings
20
Achat
2
Maintien
0
Vente
Basé sur 22 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.
Frais Généraux et Administratifs
Résultat avant impôt
Ventes
Coût des ventes
Marge brute des ventes
Charges d'intérêt sur la dette
Bénéfice d'exploitation
$